The pancreatic cancer treatment field is on fire. This is very good news because pancreatic cancer is an aggressive cancer that is typically diagnosed at late stages, and with a low survival rate (5 year survival rate of 15%).
There are a number of different treatments now undergoing clinical trials - from several vaccines, immunotherapy, the drug daraxonrasib that doubles life expectancy in those with pancreatic cancer, to other interesting treatments such as high dose vitamin C (given via IV).
The National Cancer Center's write-up: Are New Immune-Based Treatments for Kidney and Pancreatic Cancer On the Horizon?
Medscape (reputable medical site) is also writing about the promising pancreatic vaccines: Vaccine for Pancreatic Cancer and CRC Sparks Early Hope. An easier to read summary of that same study: New Vaccine May Help Stop Deadly Pancreatic Cancers From Coming Back
High-dose vitamin C (in ascorbate form, given in an IV) alongside chemotherapy for pancreatic cancer doubled survival rate and made the regular chemo drugs more tolerable for the cancer patient. From Medscape: Vitamin C’s Potential Use in Cancer Is Getting a Second Look
The drug daraxonrasib, which is awaiting FDA approval, probably this year. From NY Times: How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough